BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on Protelos® (strontium ranelate): Restriction of indication

Active substance: strontium ranelate

Recent data showing an increased risk of myocardial infarction have resulted in restrictions regarding the use of Protelos® (restricted indication, new contraindications and warnings).

Additional information:

(SPC - available in German only)

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 301KB, File is accessible